tucmas.fi BBS

The results of main and secondary efficacy endpoints are shown in Table 3 below. The authors concluded that for a affected person with advert- yielded a superior response fee and progression-free survival rel- vanced ovarian carcinoma in whom major cytoreductive surgical procedure ative to paclitaxe...